SCHEMBL2347249

SCHEMBL2347249

CCOC(=O)C(F)(F)Oc1ccc(S(C)(=O)=O)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 1/20 0.47
TSHR P16473 2/20 0.46
ABCB11 O95342 1/20 0.46
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46
HTR2A P28223 1/20 0.46
PMP22 Q01453 1/20 0.46
PPARA Q07869 1/20 0.46
GAA P10253 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
PTGS2 P35354 4/20 0.42
POLB P06746 1/20 0.42
HCRTR2 O43614 1/20 0.41
FBP1 P09467 1/20 0.40
HTT P42858 2/20 0.40
MAPT P10636 1/20 0.40
LMNA P02545 1/20 0.40
ALDH1A1 P00352 2/20 0.40
PKM P14618 1/20 0.39
OPRK1 P41145 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22374700 0.87 TSHR (0.48) EPHX2TSHRABCB11CYP1A2CYP3A4
SCHEMBL7984534 0.84 PPARA (0.66) TSHRABCB11CYP1A2CYP3A4HTR2A
SCHEMBL23519391 0.83 EPHX2 (0.52) EPHX2TSHRABCB11CYP1A2CYP3A4
SCHEMBL2348011 0.81 EPHX2 (0.51) EPHX2TSHRABCB11CYP1A2CYP3A4
SCHEMBL23519249 0.80 EPHX2 (0.50) EPHX2TSHRABCB11CYP1A2CYP3A4
SCHEMBL15897084 0.80 EPHX2 (0.50) EPHX2TSHRABCB11CYP1A2CYP3A4
SCHEMBL23519059 0.80 PTGS2 (0.47) PTGS2
SCHEMBL24497220 0.80 POLB (0.50) EPHX2TSHRABCB11CYP1A2CYP3A4
Hydrochloric Acid SCHEMBL6981964 0.79 EPHX2 (0.49) EPHX2TSHRABCB11CYP1A2CYP3A4
SCHEMBL5384911 0.79 TSHR (0.51) EPHX2TSHRABCB11CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2361243-B9 HALOALKYL CONTAINING COMPOUNDS AS CYSTEINE PROTEASE INHIBITORS VIROBAY INC (US) 2014-06-11 EP disclosed
EP-2361243-B1 HALOALKYL CONTAINING COMPOUNDS AS CYSTEINE PROTEASE INHIBITORS VIROBAY INC (US) 2013-07-03 EP disclosed
EP-2361243-A2 HALOALKYL CONTAINING COMPOUNDS AS CYSTEINE PROTEASE INHIBITORS Virobay, Inc. (US) 2011-08-31 EP disclosed
WO-2010056877-A2 HALOALKYL CONTAINING COMPOUNDS AS CYSTEINE PROTEASE INHIBITORS VIROBAY, INC. (US) 2010-05-20 WO disclosed